Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

agilon health Q3 2026 Results: Turns Profitable, Net Income $34.9M

agilon health, inc. reported a significant financial turnaround for the nine months ended September 30, 2026, achieving a net income of $101.8 million compared to a net loss of $202.5 million in the prior year period. This improvement was driven by a reduction in medical services expenses and a $19.0 million gain from discontinued operations.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1,519.51,435.3
Profit before tax38.9-110.5
Net income34.9-110.2
EPS (diluted, $ a share)$1.97$-6.65

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+5.9%
Operating margin1.6%
Source

10-Q filed with the SEC, NYSE: AGL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

agilon health, inc.: key numbers

Share price
$116.75Close, Nov 16
Market cap
$1.96B
Shares outstanding
16.8MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Misc Health & Allied Services, NECSIC 8090

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from agilon health, inc.

All →
4:29 PM ET 8-K
Investor Presentation

agilon health Investor Presentation

agilon health, inc. is hosting a virtual investor event on November 17, 2026, to present its strategic framework for driving performance at scale. The company filed a formal investor presentation deck as an exhibit, which includes discussions on its technology-enabled clinical programs and long-term growth trajectory.

4:09 PM ET 8-K
Financial Results

agilon health Financial Results

agilon health reported third quarter 2026 revenue of $1.52 billion, a 6% increase year-over-year, and a net income of $35 million compared to a net loss in the prior year. The company raised its full-year 2026 guidance for revenue and Adjusted EBITDA following stronger-than-expected performance in burden of illness and payor contracting.

“agilon’s third quarter results exceeded our expectations, reflecting the disciplined execution and operational progress our team has delivered this year. Central to that progress is our proximity to physicians and their patients, which differentiates our model and enables us to pair trusted relationships with actionable insights that help deliver better outcomes at the point of care.”

Tim O’Rourke, Chief Executive Officer of agilon health

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.